Incidence and Risk Factors of Prolonged Grief in Palliative Care Units (FAMI-LIFE)

February 10, 2021 updated by: Maité Garrouste-Orgeas, MD, GCS IHFB Cognacq-Jay

The Fami-Life Study: Protocol of a Prospective Multicenter Observational Mixed Study of Psychological Consequences of Grieving Families in French Palliative Care Units on the Behalf of the F.R.I.P.C Research Network

The purpose of this study is to assess the incidence and risk factors of prolonged grief in family members of patients died in French palliative care units and to explore experience of bereaved families to build a scientifically valid management prevention program.

Study Overview

Status

Completed

Conditions

Detailed Description

There is hardly knowledge on how bereavement is treated in palliative care patient's relatives. The field of bereavement needs studies that validate the theoretical underpinning of the research area. This study will depict the grieving process of individuals having lost a relative in palliative care in France. Having baseline data of incidence of prolonged grief, risk factors of relative's prolonged grief and identification of risk factors associated with the management of end-of-life issues in palliative care will contribute to target interventions that should help decrease bereaved families burden.

The investigator designed a quantitative study to assess the psychological effect of families after the death of the patient in palliative care unit and a qualitative study to examine the grieving prolonged process.

Study Type

Observational

Enrollment (Actual)

609

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Levallois-Perret, France, 92300
        • French British Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

The participating palliative care units belong to the French Society of Palliative Care (SFAP) and are selected using the list of the different French units on their website. An invitation of participation is sent to the clinical responsible of each unit.

The participating units belong to university, community and private hospitals.

Description

Inclusion Criteria:

  • Families of adult patients hospitalized more than 72 hours in a palliative care unit for end-of-life care.
  • Eligibility of end-of-life cares are defined after the first evaluation by the palliative care physician.

Exclusion Criteria:

  • Patients with less than 72 hours of life-expectancy
  • Patients or families who refused the study
  • Patients or families included in a study using the same questionnaires
  • Patients without families visiting them in the first 24 hours after admission
  • Patients not hospitalized for end-of-life issues
  • Families not fluent in French
  • Deaf or mute families

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of prolonged grief in bereaved family members
Time Frame: 6 months after patient's death in palliative care unit
Inventory Grief Disorder > 25
6 months after patient's death in palliative care unit
Risk factors of prolonged grief in bereaved family members
Time Frame: 6 months after patient's death in palliative care unit
Hierarchical logistic regression models with a random effect center after selection of variables by univariate analysis then introduced in a multivariate analysis
6 months after patient's death in palliative care unit

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post traumatic stress disorder in bereaved family members
Time Frame: 6 months after patient's death in palliative care unit
Impact of event Scale-revised > 22
6 months after patient's death in palliative care unit
Anxiety and depression symptoms in bereaved family members
Time Frame: 6 months after patient's death in palliative care unit
Hospital anxiety and depression scale ≥ 8
6 months after patient's death in palliative care unit
Anxiety and depression symptoms in family members
Time Frame: Between between day 3 and day 5 after patient admission in the palliative care unit
Hospital anxiety and depression scale ≥ 8
Between between day 3 and day 5 after patient admission in the palliative care unit
Report of the families' grief experience in those who have signs of prolonged grief according to the Inventory of Complicated Grief questionnaire with a score > 25
Time Frame: Between 6 and 12 months after the patient' death.
Interpretative Phenomenological Analysis
Between 6 and 12 months after the patient' death.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Chair: Jean-François Timsit, MD, PhD, INSERM 1137, IAME, Paris Diderot University, Paris

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 4, 2019

Primary Completion (Actual)

October 1, 2020

Study Completion (Actual)

February 10, 2021

Study Registration Dates

First Submitted

November 19, 2018

First Submitted That Met QC Criteria

November 19, 2018

First Posted (Actual)

November 20, 2018

Study Record Updates

Last Update Posted (Actual)

February 11, 2021

Last Update Submitted That Met QC Criteria

February 10, 2021

Last Verified

January 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • IHFB-002

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bereaved Families

3
Subscribe